Serum soluble interleukin-2 receptor in eosinophilia

被引:5
|
作者
Kaito, K
Otsubo, H
Ogasawara, Y
Kimura, H
Kurihara, E
Koike, M
Aiso, M
Kobayashi, M
机构
[1] Jikei Univ Hosp, Cent Clin Lab, Minato Ku, Tokyo 1058471, Japan
[2] Jikei Univ, Sch Med, Dept Internal Med, Div Hematol & Oncol, Tokyo, Japan
关键词
eosinophilia; IgE; interleukin-2; receptor; soluble;
D O I
10.1159/000067274
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between soluble interleukin-2 receptor (sIL-2R) levels and clinical characteristics was evaluated in patients with eosinophilia. Thirty-eight out of 60 patients showed sIL-2R levels of more than 800 U/ml. In these patients, sIL-2R was closely related to the eosinophil count, but not the IgE level. Their underlying diseases were heterogeneous, including neoplasms and collagen diseases. In patients with lower sIL-2R levels, there was no relationship to the eosinophil count, but sIL-2R was correlated with the IgE level. These findings indicate that patients with eosinophilia and higher sIL-2R levels tend to have underlying diseases other than allergy, and might be more severely ill than patients with lower sIL-2R levels. sIL-2R may be a good marker for evaluating patients with eosinophilia, as an indicator of the probable etiology and severity of their diseases. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:23 / 28
页数:6
相关论文
共 50 条
  • [31] Soluble interleukin-2 receptor in children with reflux nephropathy
    Konda, R
    Sakai, K
    Ota, S
    Takeda, A
    Chida, N
    Sato, H
    Orikasa, S
    JOURNAL OF UROLOGY, 1998, 159 (02) : 535 - 539
  • [32] THE SOLUBLE RECEPTOR OF INTERLEUKIN-2 IS NOT A SERUM MARKER OF THE AUTOIMMUNE ACTIVITY IN TYPE-1 DIABETES-MELLITUS
    VIALETTES, B
    SCHMITT, N
    HIRN, M
    HERMITTE, L
    KAPLANSKI, S
    FARNARIER, C
    MATTEIZEVACCO, C
    SIMONIN, G
    VAGUE, P
    AUTOIMMUNITY, 1991, 11 (01) : 53 - 59
  • [33] Soluble interleukin-2 receptor serum level is a useful marker of hidradenitis suppurativa clinical staging
    Matusiak, Lukasz
    Bieniek, Andrzej
    Szepietowski, Jacek C.
    BIOMARKERS, 2009, 14 (06) : 432 - 437
  • [34] Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease
    Handa, Tomohiro
    Matsui, Shoko
    Yoshifuji, Hajime
    Kodama, Yuzo
    Yamamoto, Hiroshi
    Minamoto, Seijiro
    Waseda, Yuko
    Sato, Yasuharu
    Kubo, Keishi
    Mimori, Tsuneyo
    Chiba, Tsutomu
    Hirai, Toyohiro
    Mishima, Michiaki
    MODERN RHEUMATOLOGY, 2018, 28 (05) : 838 - 844
  • [35] Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events
    Takai, Ryo
    Funakoshi, Yohei
    Suto, Hirotaka
    Nagatani, Yoshiaki
    Imamura, Yoshinori
    Toyoda, Masanori
    Yakushijin, Kimikazu
    Kiyota, Naomi
    Harada, Ken-Ichi
    Yamashita, Kimihiro
    Kakeji, Yoshihiro
    Minami, Hironobu
    ANTICANCER RESEARCH, 2021, 41 (02) : 1021 - 1026
  • [36] SERUM SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN CHRONIC PROGRESSIVE, STABLE AND STEROID-TREATED MULTIPLE-SCLEROSIS
    BANSIL, S
    TROIANO, R
    COOK, SD
    ROHOWSKYKOCHAN, C
    ACTA NEUROLOGICA SCANDINAVICA, 1991, 84 (04): : 282 - 285
  • [37] Haloperidol does not affect the level of serum-soluble interleukin-2 receptor in drug-free male schizophrenics
    Kim, CE
    Kang, DY
    Ha, KS
    Jeong, SH
    Kim, YS
    BIOLOGICAL PSYCHIATRY, 1995, 38 (12) : 843 - 845
  • [38] SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN HODGKIN DISEASE - RELATIONSHIP WITH CLINICAL STAGE, TUMOR BURDEN, AND TREATMENT OUTCOME
    AMBROSETTI, A
    NADALI, G
    VINANTE, F
    CARLINI, S
    VENERI, D
    TODESCHINI, G
    MOROSATO, L
    DESABATA, D
    CHILOSI, M
    MAGGI, E
    PARRONCHI, P
    ROMAGNANI, S
    SEMENZATO, G
    PERONA, G
    PIZZOLO, G
    CANCER, 1993, 72 (01) : 201 - 206
  • [39] Serum and cystic fluid levels of soluble interleukin-2 receptor-alpha in patients with epithelial ovarian tumors are correlated
    de Bruijn, HWA
    ten Hoor, KA
    van der Zee, AGJ
    TUMOR BIOLOGY, 1998, 19 (03) : 160 - 166
  • [40] SERUM-SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS BEFORE AND AFTER SURGICAL-TREATMENT FOR GRAVES-DISEASE
    MURAKAMI, S
    KOBAYASHI, A
    KUMA, K
    MURAI, H
    OKAMURA, Y
    SATOMI, A
    ISHIDA, K
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1995, 25 (01): : 55 - 58